Related Experiment Video
Updated: May 25, 2026
08:51
Atomic Force Microscopy Combined with Infrared Spectroscopy as a Tool to Probe Single Bacterium Chemistry
Published on: September 15, 2020
"One-size-fits-all"? Optimizing treatment duration for bacterial infections
Patricia Geli1, Ramanan Laxminarayan, Michael Dunne
1Center for Disease Dynamics, Economics and Policy, Washington, D.C., United States of America.
Plos One
|January 19, 2012
Summary
Shorter antibiotic courses can reduce resistance without harming patients, especially when immunity is present. Optimizing treatment duration and dosage is key to preserving antibiotic effectiveness.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Antibiotic guidelines historically prioritize efficacy and safety, neglecting resistance evolution.
- Antibiotic resistance poses a significant threat to public health, necessitating new treatment strategies.
Purpose of the Study:
- To explore the theoretical basis for shorter antibiotic treatment durations.
- To investigate how optimizing duration and dosing can minimize infection symptoms and resistance selection pressure.
- To assess the role of host immunity in determining optimal antibiotic treatment length.
Main Methods:
- Mathematical modeling was used to simulate bacterial ecological dynamics.
- Models considered various bacterial populations, including commensals and pathogens.
- Simulations explored the impact of treatment duration and host immunity on clinical outcomes and resistance development.
Main Results:
- Shorter antibiotic treatment durations can be effective when host immunity is present, reducing resistance selection.
- Optimizing treatment strategies based on bacterial ecology (commensal vs. invasive) can delay resistance spread.
- Mathematical models support the feasibility of shorter courses without compromising patient outcomes.
Conclusions:
- Adjusting antibiotic treatment duration and dosing can extend the therapeutic life of antibiotics.
- Host immunity is a critical factor in determining the necessity of long antibiotic courses.
- Ecological niche differences between commensal and invasive bacteria should inform treatment strategies to combat resistance.
More Related Videos
Related Concept Videos
01:23Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration
Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s half-life.
01:28Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
01:24Dosage Regimen: Individualization
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:19Dosage Interval and Administration Route: Determination Methods
A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to individual...
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...